Area of research
Molecular Biology · Organic Chemistry
Research interest
Research focused on Cancer research and Protein kinase B, with related work in Cell growth, Cell adhesion, Multiple myeloma. Notable publications include 'The role of ubiquitin‐specific protease 14 ( USP 14) in cell adhesion‐mediated drug resistance ( CAM ‐ DR ) of multiple myeloma cells', 'EphA4 promotes cell proliferation and cell adhesion–mediated drug resistance via the AKT pathway in multiple myeloma', and 'Upregulation of ADAM12 contributes to accelerated cell proliferation and cell adhesion-mediated drug resistance (CAM-DR) in Non-Hodgkin’s Lymphoma'.
EphA4 promotes cell proliferation and cell adhesion–mediated drug resistance via the AKT pathway in multiple myeloma
Upregulation of ADAM12 contributes to accelerated cell proliferation and cell adhesion-mediated drug resistance (CAM-DR) in Non-Hodgkin’s Lymphoma
ADP-ribosylation factor 1 (ARF1) takes part in cell proliferation and cell adhesion-mediated drug resistance (CAM-DR)
Silencing of CKIP-1 promotes tumor proliferation and cell adhesion-mediated drug resistance via regulating AKT activity in non-Hodgkins lymphoma
DIXDC1 promotes tumor proliferation and cell adhesion mediated drug resistance (CAM-DR) via enhancing p-Akt in Non-Hodgkin's lymphomas
RBQ3 participates in multiple myeloma cell proliferation, adhesion and chemoresistance
The role of ubiquitin‐specific protease 14 (<scp>USP</scp>14) in cell adhesion‐mediated drug resistance (<scp>CAM</scp>‐<scp>DR</scp>) of multiple myeloma cells
Silencing of DYRK2 increases cell proliferation but reverses CAM-DR in Non-Hodgkin's Lymphoma